Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences

Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences

CAMBRIDGE, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc.
(Nasdaq:IDIX), announced today that Idenix management will present a corporate
overview at the Bank of America Merrill Lynch 2013 Health Care Conference on
Wednesday, May 15, 2013 at 11:20 a.m. PT at the Encore at the Wynn in Las
Vegas, NV; and at the UBS Global Healthcare Conference on Tuesday, May 21,
2013 at 8:00 a.m. ET at the Sheraton New York Hotel in New York,
NY.Management will also host a fireside chat discussion at the Deutsche Bank
Securities 38^th Annual Health Care Conference on Thursday, May 30, 2013 at
1:30 p.m. ET at the Westin Boston Waterfront Hotel in Boston, MA.

The live and archived webcasts of the company presentations can be accessed
under "Events and Presentations" in the Idenix Investor Center at log in approximately 5-10 minutes before each event to
ensure a timely connection. The archived replay will be available on the
Idenix website for two weeks following the conferences.


Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a
biopharmaceutical Company engaged in the discovery and development of drugs
for the treatment of human viral diseases. Idenix's current focus is on the
treatment of patients with hepatitis C infection. For further information
about Idenix, please refer to

CONTACT: Idenix Pharmaceuticals Contact:
         Teri Dahlman
         (617) 995-9807

Idenix Pharmaceuticals logo
Press spacebar to pause and continue. Press esc to stop.